EUVIMEDEUVIMED entdecken
Crossref

Fibrin as the mediator of tumor cell interaction with platelets

Ivan Tesakov iD, Anna D Korneichuk, Aleksandra A Filkova, Anna E Boldova, Anna A Deputatova, Anatoly U Kokhan, Yuliya D Korol, Kristina A Mazova, Viktoria A Pakina, Anna G Poleshko, Vladislav A Shumskiy, Ekaterina V Blinova und 4 weitere

Journal of Molecular Medicine · 2025

DOI: 10.1007/s00109-025-02580-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Medicine, 2025. Verfasst von Ivan Tesakov und 15 weiteren Autor:innen. Beteiligte Einrichtung: Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology, 1 Samory Mashela Str., 117997, Moscow, Russia. Hauptthemen laut MEDLINE: Blood Platelets, Fibrin, Neoplasms, Cell Communication. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Russian Science Foundation, Belarusian Republican Foundation for Fundamental Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metastasis, a major complication in cancer, is known to depend on the interaction of tumor cells with platelets. However, anti-platelet therapy does not reliably increase survival rates. To address this, here we use light transmission aggregometry, flow cytometry, and confocal microscopy for characterization of human platelets interaction with six lines of tumor cell cultures. A murine model of Lewis carcinoma was used to test the effects of antiplatelet and anticoagulation therapy. Tumor-cell-induced platelet aggregation (TCIPA) correlated with the cell line invasive potential, required calcium and plasma proteins, and was only mildly suppressed by platelet inhibition. However, TCIPA was completely abolished by heparin, rivaroxaban, or dabigatran. For pre-fixed platelets, TCIPA was completely inhibited by the fibrin polymerization inhibitor GPRP. Tumor cells directly induced spatial fibrin polymerization in a factor X-dependent manner. Confocal microscopy confirmed platelet entrapment in the fibrin mesh formed around tumor cells. In the murine model of tumor cell injection, both anticoagulation and antiplatelet treatment reduced lung metastasis. These data suggest that formation of the fibrin mesh associated with a circulating tumor cell, with platelet entrapped in it (not necessarily in the activated state), could be an important early step in the metastasis development. KEY MESSAGES: Platelet-tumor cell heteroaggregates are stabilized by the fibrin network. Thrombin formation is induced by tumor cells, while platelet activation is less essential. Anticoagulant treatment prevents this interaction and may suppress metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood PlateletsFibrinNeoplasmsCell CommunicationAnimalsHumansPlatelet AggregationMiceCell Line, TumorPlatelet Aggregation InhibitorsMice, Inbred C57BLAnticoagulantsLung Neoplasms

Stichwörter der Autor:innen

HemostasisMetastasisPlateletsThrombinTissue factorTumor cell-induced platelet aggregation

Substanzen

FibrinPlatelet Aggregation InhibitorsAnticoagulants

Autor:innen und Institutionen

  • Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology, 1 Samory Mashela Str., 117997, Moscow, Russia.
  • Department of Oncology, Hematology, Immunology, and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
  • Center for Theoretical Problems of Physicochemical Pharmacology, Moscow, Russia.
  • Lomonosov Moscow State University, Moscow, Russia.
  • Institute of Biophysics and Cell Engineering, NAS of Belarus, Minsk, Belarus.
  • Sechenov University, Moscow, Russia.

ORCID-Profile: Ivan Tesakov

Förderung

  • Russian Science Foundation
  • Belarusian Republican Foundation for Fundamental Research

Zitieren

APA

Tesakov, I., Korneichuk, A. D., Filkova, A. A., Boldova, A. E., Deputatova, A. A., Kokhan, A. U., Korol, Y. D., Mazova, K. A., Pakina, V. A., Poleshko, A. G., Shumskiy, V. A., Blinova, E. V., Blinov, D. S., Shamova, E. V., Panteleev, M. A., & Sveshnikova, A. N. (2025). Fibrin as the mediator of tumor cell interaction with platelets. Journal of Molecular Medicine. https://doi.org/10.1007/s00109-025-02580-7

Vancouver

Tesakov I, Korneichuk AD, Filkova AA, Boldova AE, Deputatova AA, Kokhan AU, et al. Fibrin as the mediator of tumor cell interaction with platelets. Journal of Molecular Medicine. 2025. doi:10.1007/s00109-025-02580-7

BibTeX
@article{Tesakov2025,
  author = {Tesakov, Ivan and Korneichuk, Anna D and Filkova, Aleksandra A and Boldova, Anna E and Deputatova, Anna A and Kokhan, Anatoly U and Korol, Yuliya D and Mazova, Kristina A and Pakina, Viktoria A and Poleshko, Anna G and Shumskiy, Vladislav A and Blinova, Ekaterina V and Blinov, Dmitrii S and Shamova, Ekaterina V and Panteleev, Mikhail A and Sveshnikova, Anastasia N},
  title = {Fibrin as the mediator of tumor cell interaction with platelets},
  journal = {Journal of Molecular Medicine},
  year = {2025},
  doi = {10.1007/s00109-025-02580-7}
}
Kostenlos starten →